InsidersTradesSigma
Track the Equillium, Inc share price and the full insider trade history of the company, a listed equity based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.4bn. The latest transaction was filed on 4 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Connelly Stephen. Every trade is accessible without an account.
Analysts rate Equillium, Inc Strong Buy (bullish), based on 12 analysts. Average price target: US$62.05.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Equillium, Inc 是一家生物制药公司，专注于开发免疫和炎症性疾病的治疗方法。该公司在纳斯达克上市，股票代码为 EQ。